Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests using convalescent plasma to treat COVID-19 Long Hauler Syndromes because it may contain beneficial elements that target the virus.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

A young woman with late-stage Vogt-Koyanagi-Harada disease was successfully treated at a hospital.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

Vitiligo is not linked to coeliac disease, but a small number of alopecia areata patients may have it, suggesting they should be tested for coeliac disease.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

A new mouse model effectively mimics vitiligo for research and drug testing.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Talc in street cocaine can cause immune-reactive skin nodules where injected.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.